Efficacy and feasibility of robot-assisted radical cystectomy for muscle invasive bladder cancer.

Efficacy and feasibility of robot-assisted radical cystectomy for muscle invasive bladder cancer. - Efficacy and feasibility of robot-assisted radical cystectomy for muscle invasive bladder cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028263

Enrollment

Registered

2017-08-31

Start date

2017-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle invasive bladder cancer

Interventions

Robot-assisted radical cystectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with muscle invasive bladder cancer. Additionally, computerised tomography and/or magnetic resonance imaging are used to assess clinical tumour stage prior to surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who need to take antithrombogenic agents and/or have a tendency to bleed with abnormal coagulation test (PT 70-130%, APTT 76-130%) . 2. Patients who cannot be given a general anesthesia for their poor physical condition. 3. Patients with a history of extensive abdominal surgery. 4. Obese patients (body mass index over 30). 5. Patients with active infection diseases. 6. Patients who cannot keep 25 degree Trendelenburg position during operation.

Design outcomes

Primary

Measure	Time frame
Total operation and console time. Estimated blood loss.	—

Countries

Japan

Contacts

Public ContactRyosuke Ando

Nagoya City University Graduate School of Medical Sciences Department of Nephro-urology

ryo@med.nagoya-cu.ac.jp052-853-8266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026